Immutable evidence record · ticker

Regeneron Pharmaceuticals, Inc. (REGN34)

Published as observed on 21 August 2026 at 11:34 BST.

Regeneron Pharmaceuticals, Inc. has a positive company news read. Its latest completed weekly trend is negative.

As of
21 Aug 2026, 11:34
Scope
company and instrument
Evidence
14 items
Independent sources
3
Country
Brazil
Sector
Healthcare
Previous read
54.000
Change

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Regeneron Pharmaceuticals, Inc. (REGN34), 2026-08-21, https://sharemaestro.com/evidence/2d5ae0e5-1312-4dae-9529-eacdb98ed8cf/
Record checksum 0f8d4255f48115d5d89266874ca51f5494fab6805af87e56235421777211a813

Evidence context